A Phase I/II Study of Active Immunotherapy With CEA(6D)VRP Vaccine(AVX701)in Patients With Advanced or Metastatic Malignancies Expressing CEA or Stage III Colon Cancer.

Trial Profile

A Phase I/II Study of Active Immunotherapy With CEA(6D)VRP Vaccine(AVX701)in Patients With Advanced or Metastatic Malignancies Expressing CEA or Stage III Colon Cancer.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 08 Dec 2015

At a glance

  • Drugs AVX 701 (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Acronyms CEA(6D)VRP
  • Sponsors AlphaVax
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 11 Jul 2012 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
    • 01 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top